1. Home
  2. Investing
  3. Stocks
  4. USA
  6. G1 Therapeutics Inc (GTHX)
  7. Quote


G1 Therapeutics Stock Price

-1.37 (-11.36%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,826,087
Bid Price 10.55
Ask Price 11.22
News -
Day High 12.13


52 Week Range


Day Low 10.51
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
G1 Therapeutics Inc GTHX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.37 -11.36% 10.69 20:00:00
Open Price Low Price High Price Close Price Prev Close
12.13 10.51 12.13 10.65 12.06
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
17,153 1,826,087 $ 11.23 $ 20,501,026 - 10.51 - 37.06
Last Trade Time Type Quantity Stock Price Currency
19:51:34 38 $ 10.69 USD


Draw Mode:

G1 Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 454.56M 42.52M 42.25M $ 45.29M $ - -2.63 -3.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 300.00k 2.30%

more financials information »

G1 Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GTHX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week13.2713.7010.5112.501,254,938-2.58-19.44%
1 Month16.1116.4810.5113.72920,049-5.42-33.64%
3 Months15.0516.6510.5113.95962,698-4.36-28.97%
6 Months21.4424.1210.5116.651,019,202-10.75-50.14%
1 Year19.9537.0610.5120.151,156,065-9.26-46.42%
3 Years38.7441.808.8019.80718,685-28.05-72.41%
5 Years15.0069.578.8022.29549,302-4.31-28.73%

G1 Therapeutics Description

G1 Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat most types of cancer such as cell lung cancer and breast cancer and designs them to combine - and enhance - the anti-tumor activity of current therapies.

Your Recent History
G1 Therape..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.